1. Home
  2. COR
  3. COR News

Latest Cencora Inc. (COR) News on November 25, 2025

Are Medical Stocks Lagging Cencora, Inc. (COR) This Year?
COR

Zacks

4 days ago

Are Medical Stocks Lagging Cencora, Inc. (COR) This Year?

Franklin Templeton’s XRP ETF Debuts: Will Legacy Finance Finally Embrace XRP?
COR

24/7 Wall St.

5 days ago

Franklin Templeton’s XRP ETF Debuts: Will Legacy Finance Finally Embrace XRP?

E-Power Resources Inc. Announces Tetepisca Flake Graphite Property Delivers High-Value Concentrate Potential, Demonstrating High Recoveries and Premium Flake Size Distribution
COR

Newsfile

5 days ago

E-Power Resources Inc. Announces Tetepisca Flake Graphite Property Delivers High-Value Concentrate Potential, Demonstrating High Recoveries and Premium Flake Size Distribution

COR

GlobeNewswire

5 days ago

Form 8.3 - IDOX Plc - Octopus Investments

Arbiter raises $52m in funding to connect fragmented healthcare system
COR

Hospital Management

5 days ago

Arbiter raises $52m in funding to connect fragmented healthcare system

Vietnam flooding submerges homes, kills 41, after relentless rain
COR

AFP

5 days ago

Vietnam flooding submerges homes, kills 41, after relentless rain

First Rate Ventures Leads Investment in bQuest: The Care Intelligence Platform Transforming Aging and End-of-Life Planning in Financial Services
COR

Business Wire

5 days ago

First Rate Ventures Leads Investment in bQuest: The Care Intelligence Platform Transforming Aging and End-of-Life Planning in Financial Services

Moderna to onshore drug product manufacturing to Massachusetts
COR

Pharmaceutical Technology

5 days ago

Moderna to onshore drug product manufacturing to Massachusetts

Posh Turns Knowledge Into Action with Next-Generation AI Workspace for Financial Institutions
COR

Business Wire

5 days ago

Posh Turns Knowledge Into Action with Next-Generation AI Workspace for Financial Institutions

COR

MT Newswires

6 days ago

Cencora Insider Sold Shares Worth $1,868,397, According to a Recent SEC Filing

Progyny, Inc. (PGNY) Hit a 52 Week High, Can the Run Continue?
COR

Zacks

7 days ago

Progyny, Inc. (PGNY) Hit a 52 Week High, Can the Run Continue?

Take the Zacks Approach to Beat the Markets: Macy's, United Natural Foods & Monster Beverage in Focus
COR

Zacks

8 days ago

Take the Zacks Approach to Beat the Markets: Macy's, United Natural Foods & Monster Beverage in Focus

COR

MT Newswires

8 days ago

Jefferies Adjusts Price Target on Cencora to $330 From $310, Maintains Hold Rating

Here's Why Cencora (COR) is a Strong Growth Stock
COR

Zacks

11 days ago

Here's Why Cencora (COR) is a Strong Growth Stock

1 Healthcare Stock to Own for Decades and 2 We Avoid
COR

StockStory

11 days ago

1 Healthcare Stock to Own for Decades and 2 We Avoid

Why Cencora (COR) is a Top Value Stock for the Long-Term
COR

Zacks

12 days ago

Why Cencora (COR) is a Top Value Stock for the Long-Term

Cencora (COR): Assessing Valuation After Sustained Share Price Growth
COR

Simply Wall St.

13 days ago

Cencora (COR): Assessing Valuation After Sustained Share Price Growth

Why Cencora's (NYSE:COR) Earnings Are Better Than They Seem
COR

Simply Wall St.

13 days ago

Why Cencora's (NYSE:COR) Earnings Are Better Than They Seem

The 5 Most Interesting Analyst Questions From Cencora’s Q3 Earnings Call
COR

StockStory

13 days ago

The 5 Most Interesting Analyst Questions From Cencora’s Q3 Earnings Call

COR

MT Newswires

14 days ago

Wells Fargo Adjusts Price Target on Cencora to $405 From $354, Maintains Overweight Rating

COR

MT Newswires

14 days ago

JPMorgan Adjusts Price Target on Cencora to $417 From $344, Maintains Overweight Rating

Cencora Stock: Is Wall Street Bullish or Bearish?
COR

Barchart

14 days ago

Cencora Stock: Is Wall Street Bullish or Bearish?

COR

MT Newswires

15 days ago

TD Cowen Adjusts Price Target on Cencora to $400 From $350

COR

MT Newswires

18 days ago

UBS Adjusts Price Target on Cencora to $415 From $380, Maintains Buy Rating

Why Cencora (COR) is a Top Momentum Stock for the Long-Term
COR

Zacks

18 days ago

Why Cencora (COR) is a Top Momentum Stock for the Long-Term

Cencora makes $1 billion investment in pharma supply chains
COR

FreightWaves

19 days ago

Cencora makes $1 billion investment in pharma supply chains

COR

MT Newswires

19 days ago

Morgan Stanley Adjusts Price Target on Cencora to $361 From $330, Maintains Equalweight Rating

COR

MT Newswires

19 days ago

Evercore ISI Adjusts Price Target on Cencora to $400 From $340, Maintains Outperform Rating

COR

MT Newswires

19 days ago

Mizuho Adjusts Price Target on Cencora to $380 From $340, Maintains Outperform Rating

COR

MT Newswires

19 days ago

Citigroup Adjusts Price Target on Cencora to $405 From $355, Maintains Buy Rating

COR

MT Newswires

19 days ago

Baird Adjusts Price Target on Cencora to $395 From $355, Maintains Outperform Rating

Cencora (COR) Q4 Earnings and Revenues Surpass Estimates
COR

Zacks

20 days ago

Cencora (COR) Q4 Earnings and Revenues Surpass Estimates

Drug Distributor Cencora to Invest $1 Billion in U.S. Supply Chain
COR

The Wall Street Journal

20 days ago

Drug Distributor Cencora to Invest $1 Billion in U.S. Supply Chain

COR

Business Wire

20 days ago

Cencora Announces $1 Billion Investment to Strengthen Its U.S. Distribution Network

COR

MT Newswires

20 days ago

Cencora Fiscal Q4 Adjusted Earnings, Revenue Rise; Guides for Fiscal 2026 Growth

Cencora’s (NYSE:COR) Q3 Sales Top Estimates
COR

StockStory

20 days ago

Cencora’s (NYSE:COR) Q3 Sales Top Estimates

COR

Associated Press Finance

20 days ago

Cencora: Fiscal Q4 Earnings Snapshot

COR

Business Wire

20 days ago

Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results

Agilon Health (AGL) Reports Q3 Loss, Tops Revenue Estimates
COR

Zacks

21 days ago

Agilon Health (AGL) Reports Q3 Loss, Tops Revenue Estimates

Will Strong Segmental Performance Drive MCK's Top Line in Q2?
COR

Zacks

21 days ago

Will Strong Segmental Performance Drive MCK's Top Line in Q2?

Earnings To Watch: Cencora (COR) Reports Q3 Results Tomorrow
COR

StockStory

21 days ago

Earnings To Watch: Cencora (COR) Reports Q3 Results Tomorrow

Prescription for Beats: 3 Healthcare Stocks Set to Outperform in Q3
COR

Zacks

25 days ago

Prescription for Beats: 3 Healthcare Stocks Set to Outperform in Q3

Countdown to Cencora (COR) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
COR

Zacks

25 days ago

Countdown to Cencora (COR) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS

Stocks making big moves this week: Cencora, Custom Truck One Source, Kirby, Mister Car Wash, and Cardinal Health
COR

StockStory

25 days ago

Stocks making big moves this week: Cencora, Custom Truck One Source, Kirby, Mister Car Wash, and Cardinal Health

Cencora (COR) Stock Is Up, What You Need To Know
COR

StockStory

a month ago

Cencora (COR) Stock Is Up, What You Need To Know

COR

Morningstar Research

a month ago

Analyst Report: Cardinal Health, Inc.

Viatris (VTRS) Expected to Beat Earnings Estimates: Should You Buy?
COR

Zacks

a month ago

Viatris (VTRS) Expected to Beat Earnings Estimates: Should You Buy?

Cencora (COR) Earnings Expected to Grow: Should You Buy?
COR

Zacks

a month ago

Cencora (COR) Earnings Expected to Grow: Should You Buy?

Why Cencora (COR) is a Top Growth Stock for the Long-Term
COR

Zacks

a month ago

Why Cencora (COR) is a Top Growth Stock for the Long-Term

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
COR

Zacks

a month ago

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

Baxter Q3 Preview: Can Core Segments Deliver Another Solid Quarter?
COR

Zacks

a month ago

Baxter Q3 Preview: Can Core Segments Deliver Another Solid Quarter?

United State Cell and Gene Therapy Third-Party Logistics Market Analysis Report 2025-2033: Expansion Fueled by Rising R&D Expenditure, Regulatory Complexity, & Strong Demand from Major Biopharma Hubs
COR

GlobeNewswire

a month ago

United State Cell and Gene Therapy Third-Party Logistics Market Analysis Report 2025-2033: Expansion Fueled by Rising R&D Expenditure, Regulatory Complexity, & Strong Demand from Major Biopharma Hubs

COR

MT Newswires

a month ago

UBS Adjusts Cencora Price Target to $380 From $350, Maintains Buy Rating

World-Renowned Surgeon and Entrepreneur Dr. Mandeep S. Dhalla Invests in DentScribe.ai and Joins as Strategic Advisor
COR

PR Newswire

a month ago

World-Renowned Surgeon and Entrepreneur Dr. Mandeep S. Dhalla Invests in DentScribe.ai and Joins as Strategic Advisor

A Fresh Look at Cencora (COR) Valuation as Shares Rally 8% in the Past Month
COR

Simply Wall St.

a month ago

A Fresh Look at Cencora (COR) Valuation as Shares Rally 8% in the Past Month

Pharma, Specialty Units Likely to Drive Cardinal Health's Q1 Earnings
COR

Zacks

a month ago

Pharma, Specialty Units Likely to Drive Cardinal Health's Q1 Earnings

Universal Health to Report Q3 Earnings: Key Estimates to Note
COR

Zacks

a month ago

Universal Health to Report Q3 Earnings: Key Estimates to Note

What to Expect From Cencora's Q4 2025 Earnings Report
COR

Barchart

a month ago

What to Expect From Cencora's Q4 2025 Earnings Report

COR

MT Newswires

a month ago

Cencora Insider Sold Shares Worth $1,665,700, According to a Recent SEC Filing

Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report?
COR

Zacks

a month ago

Will Cencora (COR) Beat Estimates Again in Its Next Earnings Report?

How McKesson’s (MCK) Exclusive PHYRAGO Distribution Could Shape Its Specialty Pharma Growth Trajectory
COR

Simply Wall St.

a month ago

How McKesson’s (MCK) Exclusive PHYRAGO Distribution Could Shape Its Specialty Pharma Growth Trajectory

COR

Business Wire

a month ago

IntrinsiQ Specialty Solutions Expands Data Capabilities to Empower Biopharmaceutical Manufacturers and Physicians with Actionable Insights to Improve Patient Outcomes

Cycle Pharmaceuticals Launches Its First Oncology Product, PHYRAGO™ (dasatinib) Tablets, in the US
COR

Business Wire

a month ago

Cycle Pharmaceuticals Launches Its First Oncology Product, PHYRAGO™ (dasatinib) Tablets, in the US

COR

MT Newswires

a month ago

Mizuho Adjusts Price Target on Cencora to $334 From $316, Maintains Outperform Rating

The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage.
COR

Barrons.com

a month ago

The Market Took a Hit. These 6 Stocks Can Sidestep the Wreckage.

3 Market-Beating Stocks Worth Your Attention
COR

StockStory

a month ago

3 Market-Beating Stocks Worth Your Attention

3 Reasons COR Has Explosive Upside Potential
COR

StockStory

a month ago

3 Reasons COR Has Explosive Upside Potential

Does Cencora’s Strong 42% Rally Signal More Growth Ahead in 2025?
COR

Simply Wall St.

a month ago

Does Cencora’s Strong 42% Rally Signal More Growth Ahead in 2025?

Here's Why Cencora (COR) is a Strong Growth Stock
COR

Zacks

a month ago

Here's Why Cencora (COR) is a Strong Growth Stock

Bitcoin Miner Leads Two Health Care Stocks To New Highs
COR

Investor's Business Daily

a month ago

Bitcoin Miner Leads Two Health Care Stocks To New Highs

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
COR

Zacks

a month ago

Why This 1 Value Stock Could Be a Great Addition to Your Portfolio

McKesson Bets on Oncology, Biopharma as It Streamlines Portfolio
COR

Zacks

2 months ago

McKesson Bets on Oncology, Biopharma as It Streamlines Portfolio

COR

Business Wire

2 months ago

Cencora Announces Date and Time for Fourth Quarter Fiscal 2025 Earnings Release

COR

MT Newswires

2 months ago

Leerink Partners Adjusts Cencora Price Target to $361 From $349, Maintains Outperform Rating

COR

Morningstar Research

2 months ago

Analyst Report: Cencora, Inc.

COR

Morningstar Research

2 months ago

Analyst Report: McKesson Corporation

Cardinal Health Stock Scores Relative Strength Rating Upgrade
COR

Investor's Business Daily

2 months ago

Cardinal Health Stock Scores Relative Strength Rating Upgrade

2 Large-Cap Stocks with Exciting Potential and 1 We Find Risky
COR

StockStory

2 months ago

2 Large-Cap Stocks with Exciting Potential and 1 We Find Risky

Is Cencora (COR) Undervalued? Exploring the Quiet Rally and What It Means for Investors
COR

Simply Wall St.

2 months ago

Is Cencora (COR) Undervalued? Exploring the Quiet Rally and What It Means for Investors

Why Cencora (COR) is a Top Growth Stock for the Long-Term
COR

Zacks

2 months ago

Why Cencora (COR) is a Top Growth Stock for the Long-Term

1 Surging Stock with Exciting Potential and 2 We Find Risky
COR

StockStory

2 months ago

1 Surging Stock with Exciting Potential and 2 We Find Risky

COR

Morningstar Research

2 months ago

Analyst Report: McKesson Corporation

COR

Business Wire

2 months ago

Kroll Settlement Administration Announces that The Lash Group, LLC Has Reached a Settlement Regarding a Data Security Incident

Top Analyst Reports for Apple, Eli Lilly & Chevron
COR

Zacks

2 months ago

Top Analyst Reports for Apple, Eli Lilly & Chevron

Why Cencora (COR) Stock Is Trading Up Today
COR

StockStory

2 months ago

Why Cencora (COR) Stock Is Trading Up Today

nuVizz to Showcase B2B Last-Mile Delivery Strategies at CSCMP EDGE 2025
COR

GlobeNewswire

2 months ago

nuVizz to Showcase B2B Last-Mile Delivery Strategies at CSCMP EDGE 2025

COR

MT Newswires

2 months ago

Cencora Insider Sold Shares Worth $1,478,130, According to a Recent SEC Filing

Cencora (COR) is a Top-Ranked Value Stock: Should You Buy?
COR

Zacks

2 months ago

Cencora (COR) is a Top-Ranked Value Stock: Should You Buy?

COR

MT Newswires

2 months ago

Cencora Insider Sold Shares Worth $9,087,142, According to a Recent SEC Filing

COR

MT Newswires

2 months ago

Deutsche Bank Adjusts Price Target on Cencora to $322 From $328

COR

MT Newswires

2 months ago

Deutsche Bank Trims Price Target on Cencora to $322 From $328, Keeps Buy Rating

Cencora Stock: Is COR Outperforming the Health Care Sector?
COR

Barchart

2 months ago

Cencora Stock: Is COR Outperforming the Health Care Sector?

PACS Group, Inc. (PACS) Soars 24.5%: Is Further Upside Left in the Stock?
COR

Zacks

2 months ago

PACS Group, Inc. (PACS) Soars 24.5%: Is Further Upside Left in the Stock?

COR

MT Newswires

2 months ago

Argus Adjusts Price Target on Cencora to $340 From $330

COR

Argus Research

2 months ago

Analyst Report: Cencora Inc

COR

Argus Research

2 months ago

Market Digest: AAPL, COR, CCL, DECK, ETD, ETN, ORCL

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick
COR

Zacks

2 months ago

Are You a Growth Investor? This 1 Stock Could Be the Perfect Pick

Here's Why You Should Hold Cencora Stock in Your Portfolio Now
COR

Zacks

3 months ago

Here's Why You Should Hold Cencora Stock in Your Portfolio Now

Here's Why Cencora (COR) is a Strong Value Stock
COR

Zacks

3 months ago

Here's Why Cencora (COR) is a Strong Value Stock

Cencora (COR) Appoints D. Mark Durcan As New Chairman Of The Board
COR

Simply Wall St.

3 months ago

Cencora (COR) Appoints D. Mark Durcan As New Chairman Of The Board

Share on Social Networks: